| Year |
Citation |
Score |
| 2019 |
Sak M, Zumbar CT, King PD, Li X, Mifsud CS, Usubalieva A, Anderson CD, Chesnick HM, McElroy JP, Chakravarti A, Burton EC, Lehman NL. Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells. Journal of Neuro-Oncology. PMID 31011934 DOI: 10.1007/S11060-019-03164-5 |
0.378 |
|
| 2019 |
Lehman NL, Usubalieva A, Lin T, Allen SJ, Tran QT, Mobley BC, McLendon RE, Schniederjan MJ, Georgescu MM, Couce M, Dulai MS, Raisanen JM, Al Abbadi M, Palmer CA, Hattab EM, et al. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis. Acta Neuropathologica Communications. 7: 42. PMID 30876455 DOI: 10.1186/S40478-019-0689-3 |
0.39 |
|
| 2019 |
Williams B, Zumbar C, Mifsud C, Smith K, Sak M, Lehman N. EXTH-46. ALISERTIB POTENTIATES THE EFFECT OF CABOZANTINIB AND VANDETANIB AGAINST GLIOBLASTOMA CELLS Neuro-Oncology. 21: vi92-vi92. DOI: 10.1093/Neuonc/Noz175.378 |
0.357 |
|
| 2018 |
Zumbar CT, Usubalieva A, King PD, Li X, Mifsud CS, Dalton HM, Sak M, Urio S, Bryant WM, McElroy JP, Farmer G, Lehman NL. The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells. Journal of Neuro-Oncology. PMID 29396807 DOI: 10.1007/S11060-018-2755-2 |
0.349 |
|
| 2017 |
Kondo N, Barth RF, Miyatake SI, Kawabata S, Suzuki M, Ono K, Lehman NL. Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1 mutation-negative glioblastoma. Journal of Neuro-Oncology. 133: 107-118. PMID 28534152 DOI: 10.1007/s11060-017-2408-x |
0.301 |
|
| 2015 |
Puduvalli V, Giglio P, Lehman N, Ammirati M, Prevedello D, Slone W, Otero J, Huntoon K, Cunningham H, Cavezza S. Rare-18Exceptional Responders: A Personalized Approach To Targeted Treatment Of Uncommon Brain Tumors. Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov232.18 |
0.405 |
|
| 2014 |
Van Brocklyn JR, Wojton J, Meisen WH, Kellough DA, Ecsedy JA, Kaur B, Lehman NL. Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Research. 74: 5364-70. PMID 25106428 DOI: 10.1158/0008-5472.Can-14-0386 |
0.412 |
|
| 2014 |
Bourekas EC, Bell SD, Ladwig NR, Gandhe AR, Shilo K, McGregor JM, Lehman NL, Newton HB. Anaplastic papillary glioneuronal tumor with extraneural metastases. Journal of Neuropathology and Experimental Neurology. 73: 474-6. PMID 24709681 DOI: 10.1097/Nen.0000000000000061 |
0.414 |
|
| 2014 |
Hong X, O'Donnell JP, Salazar CR, Van Brocklyn JR, Barnett KD, Pearl DK, deCarvalho AC, Ecsedy JA, Brown SL, Mikkelsen T, Lehman NL. The selective Aurora-A kinase inhibitor MLN8237 (alisertib) potently inhibits proliferation of glioblastoma neurosphere tumor stem-like cells and potentiates the effects of temozolomide and ionizing radiation. Cancer Chemotherapy and Pharmacology. 73: 983-90. PMID 24627220 DOI: 10.1007/S00280-014-2430-Z |
0.41 |
|
| 2014 |
Mueller C, deCarvalho AC, Mikkelsen T, Lehman NL, Calvert V, Espina V, Liotta LA, Petricoin EF. Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations. Cancer Research. 74: 818-28. PMID 24346432 DOI: 10.1158/0008-5472.Can-13-2172 |
0.402 |
|
| 2013 |
Rutledge WC, Kong J, Gao J, Gutman DA, Cooper LA, Appin C, Park Y, Scarpace L, Mikkelsen T, Cohen ML, Aldape KD, McLendon RE, Lehman NL, Miller CR, Schniederjan MJ, et al. Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4951-60. PMID 23864165 DOI: 10.1158/1078-0432.Ccr-13-0551 |
0.365 |
|
| 2013 |
Raghunathan A, Wani K, Armstrong TS, Vera-Bolanos E, Fouladi M, Gilbertson R, Gajjar A, Goldman S, Lehman NL, Metellus P, Mikkelsen T, Necesito-Reyes MJ, Omuro A, Packer RJ, Partap S, et al. Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathology (Zurich, Switzerland). 23: 584-94. PMID 23452038 DOI: 10.1111/Bpa.12050 |
0.351 |
|
| 2013 |
Kanagal-Shamanna R, Lehman NL, O'Donnell JP, Lim MS, Schultz DS, Chitale DA, Bueso-Ramos CE, Medeiros LJ, Inamdar KV. Differential expression of aurora-A kinase in T-cell lymphomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 640-7. PMID 23411487 DOI: 10.1038/Modpathol.2012.211 |
0.332 |
|
| 2012 |
Lehman NL, O'Donnell JP, Whiteley LJ, Stapp RT, Lehman TD, Roszka KM, Schultz LR, Williams CJ, Mikkelsen T, Brown SL, Ecsedy JA, Poisson LM. Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas. Cell Cycle (Georgetown, Tex.). 11: 489-502. PMID 22274399 DOI: 10.4161/Cc.11.3.18996 |
0.388 |
|
| 2011 |
Lehman NL. Synoptic reporting for central nervous system tumors: has its time come? Archives of Pathology & Laboratory Medicine. 135: 691-2. PMID 21631259 DOI: 10.1043/2010-0673-Edi.1 |
0.353 |
|
| 2010 |
Saksena S, Jain R, Narang J, Scarpace L, Schultz LR, Lehman NL, Hearshen D, Patel SC, Mikkelsen T. Predicting survival in glioblastomas using diffusion tensor imaging metrics. Journal of Magnetic Resonance Imaging : Jmri. 32: 788-95. PMID 20882608 DOI: 10.1002/Jmri.22304 |
0.309 |
|
| 2010 |
Dulai MS, Caccamo DV, Briley AL, Edwards MS, Fisher PG, Lehman NL. Intramedullary papillary ependymoma with choroid plexus differentiation and cerebrospinal fluid dissemination to the brain. Journal of Neurosurgery. Pediatrics. 5: 511-7. PMID 20433266 DOI: 10.3171/2009.12.Peds09130 |
0.364 |
|
| 2010 |
deCarvalho AC, Nelson K, Lemke N, Lehman NL, Arbab AS, Kalkanis S, Mikkelsen T. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo. Stem Cells (Dayton, Ohio). 28: 181-90. PMID 19937755 DOI: 10.1002/Stem.264 |
0.359 |
|
| 2008 |
Lehman NL. Patterns of brain infiltration and secondary structure formation in supratentorial ependymal tumors. Journal of Neuropathology and Experimental Neurology. 67: 900-10. PMID 18716554 DOI: 10.1097/Nen.0B013E31818521Cd |
0.389 |
|
| 2008 |
Guo AM, Sheng J, Scicli GM, Arbab AS, Lehman NL, Edwards PA, Falck JR, Roman RJ, Scicli AG. Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo. The Journal of Pharmacology and Experimental Therapeutics. 327: 10-9. PMID 18591218 DOI: 10.1124/Jpet.108.140889 |
0.34 |
|
| 2008 |
Lee HK, Xiang C, Cazacu S, Finniss S, Kazimirsky G, Lemke N, Lehman NL, Rempel SA, Mikkelsen T, Brodie C. GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis. Neuro-Oncology. 10: 236-43. PMID 18403493 DOI: 10.1215/15228517-2008-006 |
0.366 |
|
| 2008 |
Lehman NL. Central nervous system tumors with ependymal features: a broadened spectrum of primarily ependymal differentiation? Journal of Neuropathology and Experimental Neurology. 67: 177-88. PMID 18344909 DOI: 10.1097/Nen.0B013E31816543A6 |
0.395 |
|
| 2008 |
Gütgemann I, Lehman NL, Jackson PK, Longacre TA. Emi1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 21: 445-54. PMID 18204430 DOI: 10.1038/Modpathol.3801022 |
0.397 |
|
| 2008 |
Dulai MS, Moes GS, Briley AL, Galperin IB, Smyth L, Cherry AM, Lehman NL. Gliosarcoma with melanocytic differentiation. Acta Neuropathologica. 115: 357-61. PMID 17641902 DOI: 10.1007/S00401-007-0232-7 |
0.347 |
|
| 2007 |
Lehman NL, Jacobs CD, Holsten PA, Jaikumar S, Lehman TD, Gibbs IC, Shuer LM. Primary paraspinal leiomyosarcoma invading the cervical spinal canal successfully treated with surgery, radiotherapy, and chemotherapy. Case report. Journal of Neurosurgery. Spine. 6: 441-6. PMID 17542511 DOI: 10.3171/Spi.2007.6.5.441 |
0.355 |
|
| 2007 |
Lehman NL, Tibshirani R, Hsu JY, Natkunam Y, Harris BT, West RB, Masek MA, Montgomery K, van de Rijn M, Jackson PK. Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. The American Journal of Pathology. 170: 1793-805. PMID 17456782 DOI: 10.2353/Ajpath.2007.060767 |
0.402 |
|
| 2005 |
Lehman NL, van de Rijn M, Jackson PK. Screening of tissue microarrays for ubiquitin proteasome system components in tumors. Methods in Enzymology. 399: 334-55. PMID 16338367 DOI: 10.1016/S0076-6879(05)99023-X |
0.331 |
|
| 2004 |
Lehman NL. Malignant PEComa of the skull base. The American Journal of Surgical Pathology. 28: 1230-2. PMID 15316324 DOI: 10.1097/01.Pas.0000128668.34934.81 |
0.415 |
|
| 2003 |
Lehman NL, Jorden MA, Huhn SL, Barnes PD, Nelson GB, Fisher PG, Horoupian DS. Cortical ependymoma. A case report and review. Pediatric Neurosurgery. 39: 50-4. PMID 12784079 DOI: 10.1159/000070881 |
0.356 |
|
| 2003 |
Lehman NL, Horoupian DS, Harsh GR. Synchronous subarachnoid drop metastases from a pituitary adenoma with multiple recurrences. Case report. Journal of Neurosurgery. 98: 1120-3. PMID 12744376 DOI: 10.3171/Jns.2003.98.5.1120 |
0.341 |
|
| 2002 |
Lehman NL, Horoupian DS, Warnke RA, Sundram UN, Peterson K, Harsh GR. Dural marginal zone lymphoma with massive amyloid deposition: rare low-grade primary central nervous system B-cell lymphoma. Case report. Journal of Neurosurgery. 96: 368-72. PMID 11838814 DOI: 10.3171/Jns.2002.96.2.0368 |
0.327 |
|
| Show low-probability matches. |